Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial

Hansen, M.S. orcid.org/0000-0001-8269-8542, Wölfel, E.M., Jeromdesella, S. et al. (6 more authors) (2024) Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial. eClinicalMedicine, 72. 102624. ISSN 2589-5370

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: Bone turnover; Cortical bone; Semaglutide; Weight loss
Dates:
  • Published: June 2024
  • Published (online): 3 May 2024
  • Accepted: 16 April 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 28 May 2024 13:58
Last Modified: 28 May 2024 13:58
Published Version: http://dx.doi.org/10.1016/j.eclinm.2024.102624
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: 10.1016/j.eclinm.2024.102624
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics